GlassScriptPhysician profile
Marla Jo Clancy
NPI 1023623436
$3,877.96
in general payments reported to CMS, 2019-2025
20 companies · $1,194 in 2025
The $1,194 reported for 2025 was more than what 84% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $92.07 · 2022: $471 · 2023: $881 · 2024: $1,240 · 2025: $1,194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,314.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $1,000.49 | 2021-2025 | Qelbree, Qelbree |
| Janssen Pharmaceuticals, INC | $396.58 | 2023-2025 | Spravato, Invega Sustenna |
| Otsuka America Pharmaceutical, INC. | $329.47 | 2021-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Corium, LLC | $322.49 | 2022-2025 | Azstarys |
| Vanda Pharmaceuticals INC. | $241.33 | 2021-2025 | Fanapt |
| Lundbeck LLC | $231.38 | 2022-2025 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $230.00 | 2022-2025 | Caplyta |
| Abbvie INC. | $206.86 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $206.39 | 2022-2025 | Austedo Xr, Austedo Xr, Austedo |
| Neurocrine Biosciences, INC. | $132.74 | 2023-2025 | Ingrezza |
| Axsome Therapeutics, INC. | $117.37 | 2022-2025 | Auvelity |
| Alkermes, INC. | $94.96 | 2023-2025 | Aristada, Lybalvi |
| E.R. Squibb & Sons, L.L.C. | $90.34 | 2025 | Cobenfy |
| Ironshore Pharmaceuticals INC. | $63.09 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $59.41 | 2022-2025 | Trintellix |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $50.02 | 2025 | Jornay Pm |
| Sunovion Pharmaceuticals INC. | $32.75 | 2021 | |
| Almatica Pharma LLC | $32.48 | 2022 | |
| Harmony Biosciences LLC | $22.05 | 2025 | |
| Biogen, INC. | $17.76 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marla Clancy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.